SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

May 15, 2025

2. SEC Identification Number

808

3. BIR Tax Identification No.

000-162-935

4. Exact name of issuer as specified in its charter

Dito CME Holdings Corp.

5. Province, country or other jurisdiction of incorporation

Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

21st Floor, Udenna Tower, Rizal Drive corner 4th Avenue, Bonifacio Global City, Taguig City Postal Code 21st

8. Issuer's telephone number, including area code

0284034007

9. Former name or former address, if changed since last report

N/A

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	21,488,500,000

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

DITO CME Holdings Corp.DITO

PSE Disclosure Form 4-30 - Material Information/Transactions References: SRC Rule 17 (SEC Form 17-C) and
Sections 4.1 and 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Restatement of the Auditor’s Report Relating to the 2023 and 2022 Comparative Consolidated Financial Statements
Background/Description of the Disclosure
During its special meeting held on 15 May 2025, the Board of Directors of the Company approved the restatement of its consolidated financial statements for the years ended 2023 and 2022 (“Restatement”), as presented in the 2024 Consolidated Audited Financial Statements for the year ended 31 December 2024 (“2024 CAFS”). The 2024 CAFS, which include the adjustments from the Restatement, was also filed with the Securities and Exchange Commission following the aforesaid Board approval. The Restatement consists of the following: 1.Attribution of the profit and losses to equity holders of the parent and non-controlling interest (NCI) using economic interest rather than voting interest consistent with Philippine Financial Reporting Standards amounting to P6,052,006,240 and P4,815,108,131 in 2023 and 2022, respectively; and, 2.Reclassification of deferred charges related to debt issue cost of undrawn portion of the project finance facility from current assets to noncurrent assets to align with the group accounting policy amounting to Php1,921,453,962 in 2023. The rationale behind the Restatement as well as the adjusted figures are discussed in Note 23 of the 2024 CAFS. Other than the foregoing, no other changes are made in the 2022 and 2023 comparative consolidated financial statements. The restatements have no effect on the Group’s total assets, total liabilities or total equity/ capital deficiency.
Other Relevant Information
None.